¼¼°èÀÇ ºÐÀÚ»ý¹°Çпë È¿¼Ò ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº° ºÐ¼®
Molecular Biology Enzymes Market Forecasts to 2030 - Global Analysis By Product (Enzymes, Kits & Reagents, DNA Extraction, Isothermal Amplification and Other Products), Application, End User and By Geography
»óǰÄÚµå : 1403390
¸®¼­Ä¡»ç : Stratistics Market Research Consulting
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200+ Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,150 £Ü 6,004,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (2-5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,350 £Ü 9,187,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,851,000
PDF & Excel (Global Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 10ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Stratistics MRC¿¡ µû¸£¸é ºÐÀÚ»ý¹°Çпë È¿¼Ò ¼¼°è ½ÃÀåÀº 2023³â 206¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 16.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 590¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÈ´Ù°í ÇÕ´Ï´Ù.

ºÐÀÚ»ý¹°Çп¡¼­ È¿¼Ò´Â »ý¹°ÀÇ ´ë»ç °úÁ¤À» °¡¼ÓÈ­Çϰí ÃËÁøÇÏ´Â Ã˸Š¿ªÇÒÀ» Çϴ Ư¼öÇÑ ´Ü¹éÁúÀÔ´Ï´Ù. È¿¼Ò´Â ƯÁ¤ È­ÇйÝÀÀÀÌ ÀϾ´Â µ¥ ÇÊ¿äÇÑ È°¼ºÈ­ ¿¡³ÊÁö¸¦ ³·Ãç¼­ ÀÛ¿ëÇϸç, ±× °úÁ¤¿¡¼­ ÀÚ¿øÀ» ¼Ò¸ðÇϰųª º¯È­½ÃŰÁö ¾Ê°íµµ ÀÌ·¯ÇÑ ¹ÝÀÀÀ» °¡¼ÓÈ­ÇÕ´Ï´Ù. È¿¼Ò´Â ƯÁ¤ °úÁ¤À̳ª °ü·Ã À̺¥Æ® ±×·ìÀ» Ã˸ÅÇϱâ À§ÇØ ¸¸µé¾îÁö±â ¶§¹®¿¡ ¸Å¿ì Ưº°ÇÕ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO) Á¶»ç¿¡ µû¸£¸é, ¾à 12,368¸íÀÌ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º ¾ç¼º¹ÝÀÀÀ» º¸¿´À¸¸ç, ±× Áß 8,423¸í(68.1%)ÀÌ AÇü, 3,945¸í(31.9%)ÀÌ BÇü ÀÎÇ÷翣ÀÚ¿¡ °¨¿°µÈ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¼ºÀå ÃËÁø¿äÀÎ: ´Ã¾î³ª´Â °Ô³ð ÇÁ·ÎÁ§Æ®

¸é¿ª°è Áúȯ, ´ë»ç¼º Áúȯ, ¾Ï, ¼±Ãµ¼º À¯ÀüÁúȯ µî Áúº´ÀÇ ¹ß»ý°ú ÁøÇàÀº À¯ÀüÀÚ º¯ÀÌ¿¡ Å« ¿µÇâÀ» ¹Þ½À´Ï´Ù. Áúº´ Ä¡·á, ¸ÂÃãÇü ÀÇ·á, ¹Ì»ý¹° À¯ÀüÇÐÀ» Æ÷ÇÔÇÑ ¸¹Àº ºÐ¾ßÀÇ ¿¬±¸´Â Àü ¼¼°èÀûÀ¸·Î ÁøÇàµÇ´Â °Ô³ð ÇÁ·ÎÁ§Æ® Áõ°¡¿Í À¯ÀüÀÚ ºÐ¼®°ú °ü·ÃµÈ ºñ¿ëÀÇ °¨¼Ò·Î ÀÎÇØ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ´Ù¾çÇÑ È¿¼Ò¿Í ½Ã¾àÀÇ »ç¿ëÀÌ ÇÊ¿äÇÑ ÀÌ·¯ÇÑ ÀýÂ÷¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ºÀå ¾ïÁ¦¿äÀÎ: À¯ÀüÀÚ °Ë»ç¿¡ ´ëÇÑ ±Þ¿© Á¦ÇÑ

º¸Çè ȯ±ÞÀÇ Á¦ÇÑÀ¸·Î ÀÎÇØ À¯ÀüÀÚ °Ë»ç¿¡ ÇÊ¿äÇÑ Æ¯Á¤ ºÐÀÚ»ý¹°ÇÐÀû È¿¼Ò¸¦ ±¸ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù. ÁÁÀº È¿¼Ò´Â °í°¡ÀÏ ¼ö ÀÖ½À´Ï´Ù. ¸¸¾à °Ë»ç ºñ¿ëÀ» Àü¾× ºÎ´ãÇÒ ¼ö ¾ø´Ù¸é, ½ÇÇè½ÇÀ̳ª ¿¬±¸¼Ò´Â ´õ Àú·ÅÇÑ ´ëüǰÀ» »ç¿ëÇÏ°Ô µÇ°í, ÀÌ´Â °Ë»çÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù. ´õ »õ·Ó°í È¿À²ÀûÀÎ È¿¼Ò¸¦ ¸¸µé·Á´Â ¿¬±¸ °³¹ß ½Ãµµ´Â Á¦ÇÑµÈ »óȯ ±Ý¾×À¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

¼ºÀå ±âȸ: ¹ßÀü Áõ°¡

Ư¼ö È¿¼Ò¿¡ ´ëÇÑ ¼ö¿ä´Â ºÐÀÚ»ý¹°ÇÐ ¿¬±¸ÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ´Ü¹éÁúÇÐ, À¯ÀüüÇÐ, ÀçÁ¶ÇÕ DNA ±â¼ú°ú °°Àº »ê¾÷ ºÐ¾ßÀÇ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ È¿¼ÒÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÁ¶ÇÕ DNA, ´Ü¹éÁú °øÇÐ ¹× È¿¼Ò °øÇÐÀÇ ¹ßÀüÀ¸·Î Ư¼ºÀÌ °­È­µÈ »õ·Î¿î È¿¼Ò°¡ »ý»êµÇ¾î ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

À§Çù: ±ÔÁ¦ Àå¾Ö¹°

ºÐÀÚ»ý¹°Çп¡ »ç¿ëµÇ´Â È¿¼Ò, ƯÈ÷ ÀÓ»ó ¹× ÀÇ·á¿¡ »ç¿ëµÇ´Â È¿¼Ò´Â ¾ö°ÝÇÑ ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã¸¦ ¹Þ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÏ°í ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ´Â °ÍÀº ºñ¿ë°ú ½Ã°£ÀÌ ¸¹ÀÌ ¼Ò¿äµÇ´Â ÀýÂ÷°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÏ°í »õ·Î¿î È¿¼Ò ¹× º¯°æ »çÇ×À» ½ÂÀÎÇÏ´Â ÀýÂ÷´Â ºñ¿ë°ú ½Ã°£ÀÌ ¸¹ÀÌ ¼Ò¿äµÉ ¼ö ÀÖ½À´Ï´Ù. À̰ÍÀÌ ½ÃÀå È®ÀåÀ» Á¦ÇÑÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

¿¬±¸ ¸ñÇ¥ÀÇ ÃÊÁ¡ÀÌ ºÐÀÚ»ý¹°ÇÐÀÇ ´Ù¸¥ ºÐ¾ß¿¡¼­ Äڷγª19 °ü·Ã ¿¬±¸·Î Å©°Ô À̵¿Çß½À´Ï´Ù. ÀÌ´Â ´Ù¾çÇÑ ¿¬±¸ ¹× ÀÀ¿ë ºÐ¾ß¿¡ »ç¿ëµÇ´Â ƯÁ¤ È¿¼Ò ǰÁ¾ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Àη ºÎÁ·, ¿î¼Û Á¦ÇÑ, ºÀ¼â·Î ÀÎÇØ °ø±Þ¸ÁÀº Å« È¥¶õÀ» °Þ¾ú½À´Ï´Ù. ÀÌ´Â ºÐÀÚ »ý¹°Çп¡ »ç¿ëµÇ´Â È¿¼Ò¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ½ÇÇè ¿ëǰÀÇ °¡¿ë¼º¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ŰƮ ¹× ½Ã¾à ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»ó

ŰƮ ¹× ½Ã¾à ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ½ÃÀå¿¡¼­ ÀÌ·¯ÇÑ Á¦Ç°ÀÇ ±¤¹üÀ§ÇÑ °¡¿ë¼º, »õ·Î¿î °³¹ß ¹× ÁÖ¿ä ±â¾÷ÀÇ Áö¼ÓÀûÀÎ Á¦Ç° Ãâ½Ã¿¡ ±âÀÎÇÕ´Ï´Ù. È¿¼Ò´Â Ç¥ÁØ ½ÇÇè ÀýÂ÷·Î¼­ º¹Á¦ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ºÐÀÚ »ý¹°ÇÐ ºÐ¾ßÀÇ È®ÀåÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î »ó½ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·Î ÀÎÇØ Á¦Á¶¾÷ü¿Í °ø±Þ¾÷ü´Â ÇÙ»ê Á¶ÀÛÀ» À§ÇÑ ¿©·¯ È¿¼Ò¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®ÀÌ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»ó

Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ¹è°æ¿¡´Â ¿öÅ©Ç÷ο츦 ¿ëÀÌÇÏ°Ô ÇÏ´Â ºÐÀÚ»ý¹°ÇÐ °ü·Ã Á¦Ç°ÀÇ º¸±ÞÀÌ ÀÖ½À´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷µéÀÌ ½Å¾à Èĺ¸¹°Áú, ¸ÂÃãÇü ÀÇ·á, Áø´Ü¾à µîÀ» ¿¬±¸ÇÒ ¶§ ÀÌ·¯ÇÑ Á¦Ç°µéÀÌ Æí¸®Çϰí È¿°úÀûÀ̱⠶§¹®¿¡ Á¦¾ÈÀÌ °­È­µÇ°í °á°úÀûÀ¸·Î ¼öÀÍÀÌ Áõ°¡ÇÕ´Ï´Ù. ÇâÈÄ ¸î ³âµ¿¾È ¿¬±¸°³¹ß ¹× ÀÓ»ó½ÃÇè ´Ü°è¸¦ ÅëÇØ ºÐÀÚ ±â¼úÀÌ ±â¾÷¿¡ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅõǴ °ÍÀÌ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ºÏ¹Ì´Â ÀÓ»ó ¹× Áß°³¿¬±¸¿¡ ´ëÇÑ ¿¬±¸ºñ Áõ°¡¿Í °¢±¹ÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾àȸ»ç ¼ö°¡ ±ÞÁõÇϸ鼭 ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ðµç ¿¬·ÉÃþ¿¡¼­ ¸¸¼ºÁúȯÀÌ ¸¸¿¬Çϰí Áö¿ª»çȸ¿¡ ¾ÏÀÌ ¸¸¿¬ÇÔ¿¡ µû¶ó ¿¹¹æ ¹× Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¿¬±¸°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ ±â¾÷ÀÇ Á¸Àç¿Í »õ·Î¿î ±â¼ú äÅÃÀÇ ¿ëÀ̼ºÀº ÀÌ Áö¿ªÀÇ ¼öÀÍ Áõ°¡¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î °£Áֵ˴ϴÙ.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÐÀÚ»ý¹°ÇÐ Á¦Á¶¾÷üµéÀº ÀÇ·á ½Ã½ºÅÛ ¹Ìºñ, Àα¸ Áõ°¡, ÁýÁß Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±Þ¼ÓÇÑ °æÁ¦ ¼ºÀåÀ¸·Î ÀÎÇØ Å« ¹ßÀü ÀáÀç·ÂÀ» ¹ß°ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌµé ±¹°¡ÀÇ ¼Òºñ·ÂÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼öÀÍÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼­À¯·´ ±â¾÷µéÀÌ ÀÌµé ±¹°¡¿¡¼­ ½ÅÁ¦Ç°À» Ãâ½ÃÇÏ°í ½ÃÀå Áö¹è·ÂÀ» È®º¸ÇÒ ¼ö ÀÖ´Â µ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÇü ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ºÐÀÚ»ý¹°ÇÐ È¿¼Ò ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ ºÐÀÚ»ý¹°ÇÐ È¿¼Ò ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ºÐÀÚ»ý¹°ÇÐ È¿¼Ò ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ ºÐÀÚ»ý¹°ÇÐ È¿¼Ò ½ÃÀå : Áö¿ªº°

Á¦9Àå ÁÖ¿ä ¹ßÀü

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

According to Stratistics MRC, the Global Molecular Biology Enzymes Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. In molecular biology, enzymes are specialized proteins that function as catalysts to quicken and ease metabolic processes in living things. They function by reducing the activation energy needed for a certain chemical reaction to take place, which speeds up these reactions without consuming any resources or changing them in the process. Because they are made to catalyze certain processes or groups of related events, enzymes are extremely specialized.

According to a survey conducted by the World Health Organization, approximately 12,368 individuals were positive for influenza viruses, of which 8,423 (68.1%) were typed as influenza A and 3,945 (31.9%) as influenza B.

Market Dynamics:

Driver:

Increasing amount of genomic projects

The genesis and progression of illnesses such immune system disorders, metabolic diseases, cancer, and inborn genetic disorders are significantly influenced by gene mutations. Research in a number of areas, including illness treatment, customized medicine, and microbial genetics, is advanced by the growing number of genome projects being undertaken worldwide and the declining costs associated with genetic analysis. The market is anticipated to be driven by these procedures, which call for the employment of a variety of enzymes and reagents.

Restraint:

Limited reimbursements for genetic testing

Reimbursement limitations limit the availability of specific molecular biology enzymes needed for genetic testing. Good enzymes can be costly; if reimbursements do not cover the entire cost, labs or research centers may choose to use less expensive substitutes, which may reduce test accuracy or efficiency. Research and development attempts to create newer, more efficient enzymes are hampered by limited reimbursement, which is hampering the growth of the market.

Opportunity:

Rising advancements

The need for specialized enzymes is driven by ongoing advances in molecular biology research as well as the necessity of enzymes for a variety of applications in industries including proteomics, genomics, and recombinant DNA technology. Additionally, advances in recombinant DNA, protein engineering, and enzyme engineering result in the production of new enzymes with enhanced characteristics, which propels market expansion.

Threat:

Regulatory hurdles

Strict regulatory oversight is frequently imposed on enzymes utilized in molecular biology, particularly when these enzymes are used in clinical or medical contexts. Ensuring compliance and meeting regulatory requirements may be costly and time-consuming procedures. It can be costly and time-consuming to comply with regulatory requirements and go through the approval procedures for new enzymes or changes. This is the main factor limiting the market's expansion.

COVID-19 Impact:

The focus of research goals moved significantly from other fields of molecular biology study to COVID-19-related investigations. This has an effect on the market for certain enzyme varieties utilized in various studies and applications. The supply chain experienced major interruptions as a result of manpower constraints, transit restrictions, and lockdowns. This has an impact on the availability of various lab supplies including enzymes used in molecular biology.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players. Enzymes are expected to rise at the quickest rate over the projection period due to the ongoing development of cloning technology as a standard laboratory procedure and the expanding field of molecular biology. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period. This can be attributed to the widespread adoption of molecular biology products that facilitate workflow. The convenience and effectiveness of these goods during the pharma and biotech businesses' research for drug candidates, customized medicine, or diagnostics enhances their offers and, as a result, increases revenues. In the upcoming years, the market will be driven by the widespread adoption of molecular technologies by businesses throughout the R&D and clinical trials phases.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to increase in research funds in clinical & translational research and surge in number of biotechnology & pharmaceutical companies in nations. Research on preventive and treatment options is growing due to the prevalence of chronic illnesses in all age groups and the ubiquity of cancer in the community. The presence of well-established players ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period the presence of bio-clusters in the nations. Manufacturers of molecular biology have found great development potential due to the deficient healthcare systems, large population, increased need for focused therapeutics, and quick economic expansion. Further encouraging western corporations to introduce new goods and win market dominance in these countries is the rising spending power of these nations, which in turn has increased market revenue.

Key players in the market:

Some of the key players in Molecular Biology Enzymes market include Illumina, Inc., Merck KGAA, Bioline Technologies, Promega Corporation, Rockland Immunochemicals, Qiagen, Agilent Technologies, Inc., Jena Bioscience GmbH, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited and Bausch Health Companies Inc.

Key Developments:

In October 2022, Illumina Inc. announced strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise.

In September 2021, Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications. The systems combine hardware and new custom-designed software to deliver fully automated incubation settings, reagent additions and precise measurement calculations, all at the touch of a button.

Products Covered:

Applications Covered:

Polymerase Chain Reaction (PCR)

End Users Covered:

Regions Covered:

What our report offers:

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Table of Contents

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Molecular Biology Enzymes Market, By Product

6 Global Molecular Biology Enzymes Market, By Application

6.2 Epigenetics

7 Global Molecular Biology Enzymes Market, By End User

8 Global Molecular Biology Enzymes Market, By Geography

9 Key Developments

10 Company Profiling

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â